Imaging genetics, which is also known as "neuroimaging genetics" or "imaging genomics," is an emerging field of study that combines genetic and neuroimaging methods to explore biological mechanisms of health and disease. Through imaging genetics, researchers can study the relationship between genetics and the brain's structure and function. This field has the potential to provide new insights into the underlying causes and progression of diseases, as well as new treatments and ways to prevent diseases. The main goal of imaging genetics is to identify genetic variants associated with differences in brain structure and function. Researchers use a variety of different imaging technologies, including magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET) scans, computed tomography (CT) scans, and magnetic resonance spectroscopy (MRS). MRI is the most commonly used imaging technique due to its high spatial resolution, meaning it can capture a large amount of detail from a single scan. In imaging genetics, researchers also look at genotypes or sequences of DNA to assess genetic variability. This information can be used to identify genetic variants associated with specific disorders as well as to analyze the precise contributions of genetic and environmental factors to a person's brain structure and function. The combination of neuroimaging and genetics can help to better understand the genetic basis of diseases, and can lead to the development of more personalized and targeted treatments. Imaging genetics is an important and rapidly growing field of study, as it provides researchers and clinicians with a powerful tool to explore the biological basis of health and disease. By using neuroimaging and genetic data together, researchers can gain a much deeper understanding of how individual variations in genes can affect brain structure and function, and therefore improve our ability to diagnose and treat complex diseases.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom